ARTICLE | Company News
Biovitrum metabolic, inflammation news
January 22, 2007 8:00 AM UTC
BVT will close its Gothenburg site and transfer all research and projects to its Stockholm site. BVT acquired the Gothenburg site when it bought Arexis AB in 2005 (see BioCentury, Aug. 29, 2005). All...